Skip to main content

Table 6 HIV risk groups of sample with at least basic behavioural and demographic data

From: Participants’ characteristics and motivations to screen for HIV vaccine and monoclonal antibody trials in KwaZulu-Natal, South Africa

 

Total

Stratified by study

 
  

100s

100/111/108

702

703/HPTN 081

Sig.

n

1384

200

989

195

 

Group 1: individual risk

     

Personal sexual risk

1124 (81.5)

44 (22)

947 (96.2)

133 (68.2)

< 0.01

Behaviour, yes n (%)

     

Transactional sex, yes n (%)

101 (7.3)

0 (0)

86 (8.7)

15 (7.7)

< 0.01

Usage of drugs, yes n (%)

305 (22)

5 (2.5)

265 (26.8)

35 (17.9)

< 0.01

Group 2: Partner risk behaviour

     

Indicated, yes n (%)

528 (38.2)

6 (3)

459 (46.4)

63 (32.3)

< 0.01

Group 3: No risks reported, n(%)

222 (16)

155 (77.5)

28 (2.8)

39 (20)

< 0.01

Group 4: HIV+, yes n (%)

87 (6.3)

15 (7.5)

72 (7.3)

0 (0)

< 0.01

Decliner, yes n (%)

263 (19)

107 (53.5)

156 (15.8)

0 (0)

< 0.01